XBRYK FDA approval date

The FDA approved XBRYK on 13 Feb 2025.

FDA approval date
13 Feb 2025

Drug identity has not yet been verified against registry records

Also recorded as DENOSUMAB-DSSB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-02-13DayXBRYKFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761392", "applicant_as_listed_by_fda": "SAMSUNG BIOEPIS CO LTD", "brand_names": ["DENOSUMAB-DSSB", "OSPOMYV", "XBRYK"], "active_ingredients": ["DENOSUMAB-DSSB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250213", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026